TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07625332: Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)

Sponsor: Northwell Health · Phase: PHASE2/PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 60 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$486,048

Rescue Site Savings

+$324,032

Unlock Full NCT07625332 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07625332 Rescue Dossier →